Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

Anton Pottegard; Sidsel Arnspang Pedersen; Sigrun Alba Johannesdottir Schmidt; Lisbet Rosenkrantz Holmich; Søren Friis; David Gaist

doi:10.1001/jamainternmed.2018.1652

Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

Anton Pottegard, Sidsel Arnspang Pedersen, Sigrun Alba Johannesdottir Schmidt, Lisbet Rosenkrantz Holmich, Søren Friis, David Gaist

44 Citations (Scopus)

Original language	English
Journal	JAMA Internal Medicine
Volume	178
Issue number	8
Pages (from-to)	1120-1122
Number of pages	3
ISSN	2168-6106
DOIs	https://doi.org/10.1001/jamainternmed.2018.1652
Publication status	Published - Aug 2018

Access to Document

10.1001/jamainternmed.2018.1652

jamainternal_pottegrd_2018_ld_180016.pdfFinal published version, 85.2 KBLicence: CC BY

Cite this

@article{468d5c2e970948e1a4d508789eabe683,

title = "Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma",

author = "Anton Pottegard and Pedersen, {Sidsel Arnspang} and Schmidt, {Sigrun Alba Johannesdottir} and Holmich, {Lisbet Rosenkrantz} and S{\o}ren Friis and David Gaist",

year = "2018",

month = aug,

doi = "10.1001/jamainternmed.2018.1652",

language = "English",

volume = "178",

pages = "1120--1122",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "The JAMA Network",

number = "8",

}

TY - JOUR

T1 - Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

AU - Pottegard, Anton

AU - Pedersen, Sidsel Arnspang

AU - Schmidt, Sigrun Alba Johannesdottir

AU - Holmich, Lisbet Rosenkrantz

AU - Friis, Søren

AU - Gaist, David

PY - 2018/8

Y1 - 2018/8

U2 - 10.1001/jamainternmed.2018.1652

DO - 10.1001/jamainternmed.2018.1652

M3 - Letter

C2 - 29813157

SN - 2168-6106

VL - 178

SP - 1120

EP - 1122

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 8

ER -